Norris Perne & French LLP MI lowered its position in Stryker Corporation (NYSE:SYK) by 4.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 19,220 shares of the medical technology company’s stock after selling 851 shares during the period. Norris Perne & French LLP MI’s holdings in Stryker were worth $2,976,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SYK. Koch Industries Inc. boosted its position in Stryker by 34,120.3% in the second quarter. Koch Industries Inc. now owns 1,260,675 shares of the medical technology company’s stock valued at $1,252,000 after buying an additional 1,256,991 shares during the last quarter. BlackRock Inc. boosted its position in Stryker by 5.2% in the second quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock valued at $3,208,017,000 after buying an additional 1,139,082 shares during the last quarter. Janus Henderson Group PLC boosted its position in Stryker by 2,237.8% in the second quarter. Janus Henderson Group PLC now owns 1,019,254 shares of the medical technology company’s stock valued at $141,452,000 after buying an additional 975,656 shares during the last quarter. Vanguard Group Inc. boosted its position in Stryker by 2.8% in the second quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after buying an additional 657,656 shares during the last quarter. Finally, APG Asset Management N.V. boosted its position in Stryker by 117.1% in the third quarter. APG Asset Management N.V. now owns 583,736 shares of the medical technology company’s stock valued at $82,902,000 after buying an additional 314,800 shares during the last quarter. Hedge funds and other institutional investors own 74.91% of the company’s stock.

Stryker Corporation (SYK) traded up $1.24 during trading on Tuesday, reaching $162.52. The company’s stock had a trading volume of 1,354,600 shares, compared to its average volume of 1,246,443. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a 1-year low of $119.17 and a 1-year high of $164.20. The stock has a market cap of $60,760.00, a price-to-earnings ratio of 34.65, a PEG ratio of 2.31 and a beta of 0.78.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.02. Stryker had a return on equity of 24.11% and a net margin of 14.67%. The business had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.97 billion. During the same quarter in the prior year, the firm posted $1.39 EPS. The business’s quarterly revenue was up 6.1% compared to the same quarter last year. sell-side analysts forecast that Stryker Corporation will post 6.49 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be paid a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 1.16%. This is an increase from Stryker’s previous quarterly dividend of $0.43. The ex-dividend date is Thursday, December 28th. Stryker’s dividend payout ratio is presently 40.09%.

SYK has been the topic of a number of recent research reports. Wells Fargo & Co upped their target price on Stryker from $160.00 to $166.00 in a research report on Friday, October 27th. Canaccord Genuity upped their target price on Stryker from $155.00 to $162.00 and gave the company a “buy” rating in a research report on Friday, October 27th. Stifel Nicolaus upped their target price on Stryker from $158.00 to $168.00 and gave the company a “buy” rating in a research report on Friday, October 27th. Cowen set a $160.00 target price on Stryker and gave the company a “buy” rating in a research report on Friday, October 6th. Finally, Royal Bank of Canada reiterated a “buy” rating and issued a $155.00 target price on shares of Stryker in a research report on Monday, October 2nd. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and thirteen have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $156.60.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the transaction, the insider now directly owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 7.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (SYK) Shares Sold by Norris Perne & French LLP MI” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://theolympiareport.com/2018/01/23/stryker-corporation-syk-shares-sold-by-norris-perne-french-llp-mi.html.

Stryker Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.